Go to JCI Insight
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact
  • Clinical Research and Public Health
  • Current issue
  • Past issues
  • By specialty
    • COVID-19
    • Cardiology
    • Gastroenterology
    • Immunology
    • Metabolism
    • Nephrology
    • Neuroscience
    • Oncology
    • Pulmonology
    • Vascular biology
    • All ...
  • Videos
    • Conversations with Giants in Medicine
    • Video Abstracts
  • Reviews
    • View all reviews ...
    • Complement Biology and Therapeutics (May 2025)
    • Evolving insights into MASLD and MASH pathogenesis and treatment (Apr 2025)
    • Microbiome in Health and Disease (Feb 2025)
    • Substance Use Disorders (Oct 2024)
    • Clonal Hematopoiesis (Oct 2024)
    • Sex Differences in Medicine (Sep 2024)
    • Vascular Malformations (Apr 2024)
    • View all review series ...
  • Viewpoint
  • Collections
    • In-Press Preview
    • Clinical Research and Public Health
    • Research Letters
    • Letters to the Editor
    • Editorials
    • Commentaries
    • Editor's notes
    • Reviews
    • Viewpoints
    • 100th anniversary
    • Top read articles

  • Current issue
  • Past issues
  • Specialties
  • Reviews
  • Review series
  • Conversations with Giants in Medicine
  • Video Abstracts
  • In-Press Preview
  • Clinical Research and Public Health
  • Research Letters
  • Letters to the Editor
  • Editorials
  • Commentaries
  • Editor's notes
  • Reviews
  • Viewpoints
  • 100th anniversary
  • Top read articles
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact

Citations to this article

Excessive insulin receptor serine phosphorylation in cultured fibroblasts and in skeletal muscle. A potential mechanism for insulin resistance in the polycystic ovary syndrome.
A Dunaif, … , E Schenker, Z Tang
A Dunaif, … , E Schenker, Z Tang
Published August 1, 1995
Citation Information: J Clin Invest. 1995;96(2):801-810. https://doi.org/10.1172/JCI118126.
View: Text | PDF
Research Article Article has an altmetric score of 7

Excessive insulin receptor serine phosphorylation in cultured fibroblasts and in skeletal muscle. A potential mechanism for insulin resistance in the polycystic ovary syndrome.

  • Text
  • PDF
Abstract

We investigated the cellular mechanisms of the unique disorder of insulin action found in the polycystic ovary syndrome (PCOS). Approximately 50% of PCOS women (PCOS-Ser) had a significant increase in insulin-independent beta-subunit [32P]phosphate incorporation (3.7-fold, P < 0.05 vs other groups) in skin fibroblast insulin receptors that was present in serine residues while insulin-induced tyrosine phosphorylation was decreased (both P < 0.05 vs other groups). PCOS skeletal muscle insulin receptors had the same abnormal phosphorylation pattern. The remaining PCOS women (PCOS-n1) had basal and insulin-stimulated receptor autophosphorylation similar to control. Phosphorylation of the artificial substrate poly GLU4:TYR1 by the PCOS-Ser insulin receptors was significantly decreased (P < 0.05) compared to control and PCOS-n1 receptors. The factor responsible for excessive serine phosphorylation appeared to be extrinsic to the receptor since no insulin receptor gene mutations were identified, immunoprecipitation before autophosphorylation corrected the phosphorylation defect and control insulin receptors mixed with lectin eluates from affected PCOS fibroblasts displayed increased serine phosphorylation. Our findings suggest that increased insulin receptor serine phosphorylation decreases its protein tyrosine kinase activity and is one mechanism for the post-binding defect in insulin action characteristic of PCOS.

Authors

A Dunaif, J Xia, C B Book, E Schenker, Z Tang

×

Total citations by year

Year: 2025 2024 2023 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011 2010 2009 2008 2007 2006 2005 2004 2003 2002 2001 2000 1999 1998 1997 1996 1964 1957 Total
Citations: 3 6 8 9 11 11 2 6 10 7 8 12 9 19 5 11 19 22 21 19 25 14 15 15 13 11 16 22 7 6 1 1 364
Citation information
This citation data is accumulated from CrossRef, which receives citation information from participating publishers, including this journal. Not all publishers participate in CrossRef, so this information is not comprehensive. Additionally, data may not reflect the most current citations to this article, and the data may differ from citation information available from other sources (for example, Google Scholar, Web of Science, and Scopus).

Citations to this article (364)

Title and authors Publication Year
Polycystic ovary syndrome and epithelial-mesenchymal transition: Mendelian randomization and single-cell analysis insights
Liu D, Liu D, Zhou K
Journal of Ovarian Research 2025
Reappraising the relationship between hyperinsulinemia and insulin resistance in PCOS
Houston EJ, Templeman NM
The Journal of Endocrinology 2025
Polycystic Ovary Syndrome: An Evolutionary Metabolic Adaptation
Dumesic DA, Padmanabhan V, Abbott DH
Reproduction (Cambridge, England) 2025
Association of Fat Mass and Skeletal Muscle Mass with Cardiometabolic Risk Varied in Distinct PCOS Subtypes: A Propensity Score-Matched Case-Control Study.
Cai J, Yue J, Lu N, Li S, Zheng J, Huang R, Jiang Y, Shan C, Liu W, Ma J, Wang L
Journal of Clinical Medicine 2024
Polycystic ovary syndrome.
Stener-Victorin E, Teede H, Norman RJ, Legro R, Goodarzi MO, Dokras A, Laven J, Hoeger K, Piltonen TT
Nature Reviews Disease Primers 2024
The serine phosphorylations in the IRS-1 PIR domain abrogate IRS-1 and IR interaction
Woo JR, Bae SH, Wales TE, Engen JR, Lee J, Jang H, Park S
Proceedings of the National Academy of Sciences 2024
Role of Omega-3 Fatty Acids in Improving Metabolic Dysfunctions in Polycystic Ovary Syndrome
Albardan L, Platat C, Kalupahana NS
Nutrients 2024
Obesity and Polycystic Ovary Syndrome
Kim JJ
Journal of Obesity & Metabolic Syndrome 2024
PCOS - the many faces of a disorder in women and men.
Lafci NG, Yilmaz B, Yildiz BO
Journal of endocrinological investigation 2024
Insulin Metabolism in Polycystic Ovary Syndrome: Secretion, Signaling, and Clearance.
Herman R, Sikonja J, Jensterle M, Janez A, Dolzan V
International journal of molecular sciences 2023
Molecular characterization of extracellular vesicles derived from follicular fluid of women with and without PCOS: integrating analysis of differential miRNAs and proteins reveals vital molecules involving in PCOS.
Yang Y, Lang P, Zhang X, Wu X, Cao S, Zhao C, Shen R, Ling X, Yang Y, Zhang J
Journal of Assisted Reproduction and Genetics 2023
Insulin Resistance and Bone Metabolism Markers in Women with Polycystic Ovary Syndrome: A Cross-Sectional Study on Females from the Islamic University Medical Center.
Aldhafiri FK, Abdelgawad FE, Mohamed Bakri GM, Saber T
2023
Pathophysiology and Nutritional Approaches in Polycystic Ovary Syndrome (PCOS): A Comprehensive Review.
Di Lorenzo M, Cacciapuoti N, Lonardo MS, Nasti G, Gautiero C, Belfiore A, Guida B, Chiurazzi M
Current Nutrition Reports 2023
Mechanism and recent updates on insulin-related disorders.
Kumar S, Senapati S, Bhattacharya N, Bhattacharya A, Maurya SK, Husain H, Bhatti JS, Pandey AK
World journal of clinical cases 2023
Lean mass and associated factors in women with PCOS with different phenotypes.
Fighera TM, Dos Santos BR, Spritzer PM
PloS one 2023
DHT and Insulin Upregulate Secretion of the Soluble Decoy Receptor of IL-33 From Decidualized Endometrial Stromal Cells.
Salamon D, Ujvari D, Hellberg A, Hirschberg AL
Endocrinology 2023
Adipose Tissue Dysfunction in Polycystic Ovary Syndrome
Bril F, Ezeh U, Amiri M, Hatoum S, Pace L, Chen YH, Bertrand F, Gower B, Azziz R
The Journal of clinical endocrinology and metabolism 2023
Current Perspectives on Nonalcoholic Fatty Liver Disease in Women with Polycystic Ovary Syndrome.
Wang D, He B
Diabetes, metabolic syndrome and obesity : targets and therapy 2022
A brief insight into the etiology, genetics, and immunology of polycystic ovarian syndrome (PCOS).
Siddiqui S, Mateen S, Ahmad R, Moin S
Journal of Assisted Reproduction and Genetics 2022
Efficacy of Myo-inositol on Anthropometric, Metabolic, and Endocrine Outcomes in PCOS Patients: a Meta-analysis of Randomized Controlled Trial.
Jethaliya H, Gajjar N, Patel V, Deshpande S, Patel R
Reproductive sciences (Thousand Oaks, Calif.) 2022
Effects of Different Ovulation Induction Regimens on Sex Hormone Levels and Serum CTRP3 and CTRP15 Levels in Patients with Polycystic Ovary Syndrome (PCOS).
Ren M, Liu J, Zhang Y, Fan L
BioMed Research International 2022
Characterizing skeletal muscle dysfunction in women with polycystic ovary syndrome.
McDonnell T, Cussen L, McIlroy M, O'Reilly MW
Therapeutic Advances in Endocrinology and Metabolism 2022
Deconstructing a Syndrome: Genomic Insights Into PCOS Causal Mechanisms and Classification.
Dapas M, Dunaif A
Endocrine reviews 2022
The polycystic ovary syndrome: the first 150 years of study.
Adashi EY, Cibula D, Peterson M, Azziz R
2022
Female infertility in the era of obesity: The clash of two pandemics or inevitable consequence?
Medenica S, Spoltore ME, Ormazabal P, Marina LV, Sojat AS, Faggiano A, Gnessi L, Mazzilli R, Watanabe M
Clinical Endocrinology 2022
A Review of Special Considerations on Insulin Resistance Induced Hyperandrogenemia in Women with Polycystic Ovary Syndrome: A Prominent COVID-19 Risk Factor.
Roozbeh J, Janfeshan S, Afshari A, Doostkam A, Yaghobi R
International journal of molecular and cellular medicine 2022
The role of polymorphism in various potential genes on polycystic ovary syndrome susceptibility and pathogenesis
H Chaudhary, J Patel, NK Jain, R Joshi
Journal of Ovarian Research 2021
Role of insulin and insulin resistance in androgen excess disorders
K Unluhizarci, Z Karaca, F Kelestimur
World journal of diabetes 2021
Defining the underlying defect in insulin action in type 2 diabetes
TM Batista, N Haider, CR Kahn
Diabetologia 2021
Nutritional guidelines for the management of insulin resistance
G Muscogiuri, L Barrea, M Caprio, F Ceriani, AO Chavez, ME Ghoch, E Frias-Toral, RJ Mehta, V Mendez, SA Paschou, A Pazderska, S Savastano, A Colao
Critical Reviews in Food Science and Nutrition 2021
A review on inositol’s potential in cyclic disturbances of adipose-endocrinology-associated polycystic ovary syndrome
WH Almalki
Molecular and Cellular Biochemistry 2021
Metformin does not improve insulin sensitivity over hypocaloric diets in women with polycystic ovary syndrome: a systematic review of 12 studies
SC Garcia-Hernandez, LM Porchia, BT Pacheco-Soto, E López-Bayghen, ME Gonzalez-Mejia
Gynecological Endocrinology 2021
Polycystic Ovary Syndrome in Insulin-Resistant Adolescents with Obesity: The Role of Nutrition Therapy and Food Supplements as a Strategy to Protect Fertility
V Calcaterra, E Verduci, H Cena, VC Magenes, CF Todisco, E Tenuta, C Gregorio, RD Giuseppe, A Bosetti, ED Profio, G Zuccotti
Nutrients 2021
Assessment of Early Markers of Cardiovascular Risk in Polycystic Ovary Syndrome
KI Alexandraki, EA Kandaraki, KA Poulia, C Piperi, E Papadimitriou, TG Papaioannou
2021
PCOS Modulatory Activity of Tinospora cordifolia leaves – An Insilico Approach
MS Devi, PM Muralidharan, R Hari, M Lavanya, TA Abiraamavalli
2021
STUDY OF SERUM IRISIN AND ITS ASSOCIATION WITH INSULIN RESISTANCE IN POLY CYSTIC OVARY SYNDROME
GG Kaushik, P Chaudhary, A Sharma
2021
Assessment of Early Markers of Cardiovascular Risk in Polycystic Ovary Syndrome.
Alexandraki KI, Kandaraki EA, Poulia KA, Piperi C, Papadimitriou E, Papaioannou TG
2021
From Prediabetes to Type 2 Diabetes Mellitus in Women with Polycystic Ovary Syndrome: Lifestyle and Pharmacological Management
A Pani, I Gironi, GD Vieste, E Mion, F Bertuzzi, B Pintaudi
International Journal of Endocrinology 2020
Implicating androgen excess in propagating metabolic disease in polycystic ovary syndrome
P Kempegowda, E Melson, KN Manolopoulos, W Arlt, MW OReilly
Therapeutic Advances in Endocrinology and Metabolism 2020
Metabolic dysfunction in polycystic ovary syndrome: Pathogenic role of androgen excess and potential therapeutic strategies
MA Sanchez-Garrido, M Tena-Sempere
Molecular Metabolism 2020
Insulin resistance and PCOS: chicken or egg?
P Moghetti, F Tosi
Journal of Endocrinological Investigation 2020
Molecular Mechanisms of Laparoscopic Ovarian Drilling and Its Therapeutic Effects in Polycystic Ovary Syndrome
KM Seow, YW Chang, KH Chen, CC Juan, CY Huang, LT Lin, KH Tsui, YJ Chen, WL Lee, PH Wang
International journal of molecular sciences 2020
A Systematic Review of the Effects of Exercise on Hormones in Women with Polycystic Ovary Syndrome
G Shele, J Genkil, D Speelman
Journal of Functional Morphology and Kinesiology 2020
The Role of Zinc in Selected Female Reproductive System Disorders
M Nasiadek, J Stragierowicz, M Klimczak, A Kilanowicz
Nutrients 2020
Effects of lifestyle modification in polycystic ovary syndrome compared to metformin only or metformin addition: A systematic review and meta-analysis
CH Kim, SJ Chon, SH Lee
Scientific Reports 2020
The role of advanced glycation end products in human infertility
J Zhu, Y Cai, S Long, Z Chen, Z Mo
Life Sciences 2020
Síndrome de ovarios poliquísticos
G Robin, M Peigne, A Dumont, P Plouvier, AL Rolland, S Catteau-Jonard, D Dewailly
EMC - Ginecología-Obstetricia 2020
Polycystic Ovary Syndrome and Gender Identity
Minghao Liu, Swetha Murthi, Leonid Poretsky
The Yale journal of biology and medicine 2020
Excess androgen production in subcutaneous adipose tissue of women with polycystic ovarian syndrome is not related to insulin or LH
SA Amer, NG Alzanati, A Warren, R Tarbox, R Khan
Journal of Endocrinology 2019
Insulin Resistance: Childhood Precursors of Adult Disease
PS Zeitler, KJ Nadeau
2019
Role of Lipotoxicity and Contribution of the Renin-Angiotensin System in the Development of Polycystic Ovary Syndrome
A Connolly, S Leblanc, JP Baillargeon
International Journal of Endocrinology 2018
Comparison of glycemic control and β-cell function in new onset T2DM patients with PCOS of metformin and saxagliptin monotherapy or combination treatment
T Tao, P Wu, Y Wang, W Liu
BMC Endocrine Disorders 2018
Bilan avant assistance médicale à la procréation : le versant féminin
G Robin
Revue Francophone des Laboratoires 2018
Metabolic syndrome in women with polycystic ovary syndrome
S Chandrasekaran, H Sagili
The Obstetrician & Gynaecologist 2018
Transcriptional and Epigenetic Changes Influencing Skeletal Muscle Metabolism in Women With Polycystic Ovary Syndrome
E Nilsson, A Benrick, M Kokosar, A Krook, E Lindgren, T Källman, MM Martis, K Højlund, C Ling, E Stener-Victorin
The Journal of clinical endocrinology and metabolism 2018
Resolvin D1 impacts on insulin resistance in women with polycystic ovary syndrome and healthy women
N Morshedzadeh, A Saedisomeolia, M Djalali, MR Eshraghian, S Hantoushzadeh, M Mahmoudi
Diabetes & Metabolic Syndrome: Clinical Research & Reviews 2018
Cardiometabolic Risk in PCOS: More than a Reproductive Disorder
LC Torchen
Current Diabetes Reports 2017
The effect of vitamin D supplementation in combination with low-calorie diet on anthropometric indices and androgen hormones in women with polycystic ovary syndrome: a double-blind, randomized, placebo-controlled trial
S Jafari-Sfidvajani, R Ahangari, M Hozoori, H Mozaffari-Khosravi, H Fallahzadeh, A Nadjarzadeh
Journal of Endocrinological Investigation 2017
Pediatric Obesity
MS Freemark
Pediatric Obesity 2017
New biomarkers for diagnosis and management of polycystic ovary syndrome
SE Karakas
Clinica chimica acta; international journal of clinical chemistry 2017
Effect of Non-Surgical Periodontal Therapy Along With Myo-Inositol on High-Sensitivity C-Reactive Protein and Insulin Resistance in Women With Polycystic Ovary Syndrome and Chronic Periodontitis: A Randomized Controlled Trial
Deepti, S Tewari, SC Narula, SR Singhal, RK Sharma
Journal of Periodontology 2017
Polycystic ovarian syndrome: Assessment of approaches to diagnosis and cardiometabolic monitoring in UK primary care
AH Heald, M Livingston, D Holland, J Robinson, GY Moreno, G Donnahey, CJ Duff, P Wu, AA Fryer
International Journal of Clinical Practice 2017
Effects of myo-inositol, gymnemic acid, and L-methylfolate in polycystic ovary syndrome patients
M Stracquadanio, L Ciotta, MA Palumbo
Gynecological Endocrinology 2017
Polycystic ovarian syndrome: Social situation influences outcome
M Livingston, D Holland, A Kalansooriya, GY Moreno, G Donnahey, CJ Duff, P Wu, AA Fryer, AH Heald
International Journal of Clinical Practice 2017
CXC Ligand 5 cytokine serum level in women with polycystic ovary syndrome and normal body mass index: A case-control study
M Zohrabi, E Rahmani, N Motamed, S Akbarzadeh
International Journal of Reproductive Biomedicine 2017
Clinical, Biochemical, and Hormonal Associations in Female Patients with Acne: A Study and Literature Review
Sujata Mehta-Ambalal
The Journal of clinical and aesthetic dermatology 2017
Genetic Rodent Models of Obesity-Associated Ovarian Dysfunction and Subfertility: Insights into Polycystic Ovary Syndrome
I Huang-Doran, S Franks
Frontiers in Endocrinology 2016
Metabolism and Ovarian Function in PCOS Women: A Therapeutic Approach with Inositols
AS Laganà, P Rossetti, M Buscema, SL Vignera, RA Condorelli, G Gullo, R Granese, O Triolo
International Journal of Endocrinology 2016
Polycystic ovary syndrome
R Azziz, E Carmina, ZJ Chen, A Dunaif, JS Laven, RS Legro, D Lizneva, B Natterson-Horowtiz, HJ Teede, BO Yildiz
Nature Reviews Disease Primers 2016
Inhibition of MEK1 Signaling Pathway in the Liver Ameliorates Insulin Resistance
A Ueyama, N Ban, M Fukazawa, T Hirayama, M Takeda, T Yata, H Muramatsu, M Hoshino, M Yamamoto, M Matsuo, Y Kawashima, T Iwase, T Kitazawa, Y Kushima, Y Yamada, Y Kawabe
Journal of Diabetes Research 2016
Principles of Diabetes Mellitus
A Ohri, S Vergano, R Bhambri, SH Schneider
Principles of Diabetes Mellitus 2016
Nutrients as novel therapeutic approaches for metabolic disturbances in polycystic ovary syndrome
Asieh Mansour, Saeed Hosseini, Bagher Larijani, Mohammad Reza Mohajeri-Tehrani
EXCLI J 2016
PHYSIOLOGY AND ENDOCRINOLOGY SYMPOSIUM: Insulin action and lipotoxicity in the development of polycystic ovary syndrome: A review1
J Faubert, MC Battista, JP Baillargeon
Journal of animal science 2016
Endocrine causes of nonalcoholic fatty liver disease
L Marino
World journal of gastroenterology : WJG 2015
Peripheral insulin resistance in obese girls with hyperandrogenism is related to oxidative phosphorylation and elevated serum free fatty acids
M Cree-Green, BR Newcomer, G Coe, L Newnes, A Baumgartner, MS Brown, L Pyle, JE Reusch, KJ Nadeau
American journal of physiology. Endocrinology and metabolism 2015
Oxidative stress and cardiovascular complications in polycystic ovarian syndrome
BN Hyderali, K Mala
European Journal of Obstetrics & Gynecology and Reproductive Biology 2015
The beneficial effects of tetracosanol on insulin-resistance by insulin receptor kinase sensibilisation
CY Hsu, HY Shih, YC Chang, ZL Huang, MJ Tsai, YC Chia, C Chen, YK Lai, CF Weng
Journal of Functional Foods 2015
Scientific Statement on the Diagnostic Criteria, Epidemiology, Pathophysiology, and Molecular Genetics of Polycystic Ovary Syndrome
DA Dumesic, SE Oberfield, E Stener-Victorin, JC Marshall, JS Laven, RS Legro
Endocrine reviews 2015
Genetic variation in insulin-induced kinase signaling
IX Wang, G Ramrattan, VG Cheung
Molecular Systems Biology 2015
Metabolic Aspects of PCOS
M Stracquadanio, L Ciotta
2015
STUDY OF ADOLESCENT GIRLS WITH MENSTRUALIRREGULARITIES FOR POLYCYSTIC OVARIES AND INSULIN RESISTANCE
S Kumari, S Pankaj, K Kavita, V Choudhary, RK H
2015
Insulin Receptor Signaling in Normal and Insulin-Resistant States
J Boucher, A Kleinridders, CR Kahn
Cold Spring Harbor perspectives in biology 2014
Polycystic Ovary Syndrome, Insulin Resistance, and Obesity: Navigating the Pathophysiologic Labyrinth
J Rojas, M Chávez, L Olivar, M Rojas, J Morillo, J Mejías, M Calvo, V Bermúdez
International Journal of Reproductive Medicine 2014
Regulation of androgen biosynthesis – A short review and preliminary results from the hyperandrogenic starvation NCI-H295R cell model
P Kempná, N Marti, S Udhane, CE Flück
Molecular and Cellular Endocrinology 2014
The Role of Metformin in Metabolic Disturbances during Pregnancy: Polycystic Ovary Syndrome and Gestational Diabetes Mellitus
J Rojas, M Chávez-Castillo, V Bermúdez
International Journal of Reproductive Medicine 2014
Cellular Endocrinology in Health and Disease
AA Bremer, WL Miller
Cellular Endocrinology in Health and Disease 2014
The effects of adipocytokines on the endocrino-metabolic features and obstetric outcome in pregnant obese women with polycystic ovary syndrome
DG Elkholi, HM Nagy
Middle East Fertility Society Journal 2014
Family-based analysis of INSR polymorphisms in Chinese PCOS
J Du, J Wang, X Sun, X Xu, F Zhang, B Wang, Y Shi, Z Chen
Reproductive BioMedicine Online 2014
Dihydrotestosterone deteriorates cardiac insulin signaling and glucose transport in the rat model of polycystic ovary syndrome
S Tepavčević, DV Milutinović, D Macut, Z Žakula, M Nikolić, I Božić-Antić, S Romić, J Bjekić-Macut, G Matić, G Korićanac
The Journal of Steroid Biochemistry and Molecular Biology 2014
Rutin potentiates insulin receptor kinase to enhance insulin-dependent glucose transporter 4 translocation
CY Hsu, HY Shih, YC Chia, CH Lee, H Ashida, YK Lai, CF Weng
Molecular Nutrition & Food Research 2014
Zinc and Homocysteine Levels in Polycystic Ovarian Syndrome Patients with Insulin Resistance
I Guler, O Himmetoglu, A Turp, A Erdem, M Erdem, MA Onan, C Taskiran, MY Taslipinar, H Guner
Biological Trace Element Research 2014
The impact of prenatal exposure to a single dose of testosterone on insulin resistance, glucose tolerance and lipid profile of female rat’s offspring in adulthood
M Noroozzadeh, FR Tehrani, K Sedaghat, A Godini, F Azizi
Journal of Endocrinological Investigation 2014
Long term complications of polycystic ovary syndrome (PCOS)
M Peigné, D Dewailly
Annales d'Endocrinologie 2014
miRNA-93 inhibits GLUT4 and is overexpressed in adipose tissue of polycystic ovary syndrome patients and women with insulin resistance
YH Chen, S Heneidi, JM Lee, LC Layman, DW Stepp, GM Gamboa, BS Chen, G Chazenbalk, R Azziz
Diabetes 2013
Phosphorylation of human cytochrome P450c17 by p38α selectively increases 17,20 lyase activity and androgen biosynthesis
MK Tee, WL Miller
The Journal of biological chemistry 2013
Endocrine and clinical effects of myo-inositol administration in polycystic ovary syndrome. A randomized study*
PG Artini, OM di Berardino, F Papini, AD Genazzani, G Simi, M Ruggiero, V Cela
Gynecological Endocrinology 2013
Utility of Hemoglobin-AIC in Nondiabetic Women with Polycystic Ovary Syndrome (PCOS)
R Mortada, K Comerford, KJ Kallail, SE Karakas
Endocrine Practice 2013
Importance of elevated insulin resistance, dyslipidemia and status of antioxidant vitamins in polycystic ovary disease
JN Naidu, GN Swapna, AN Kumar, M Krishnamma, M Anitha
Free Radicals and Antioxidants 2013
Metabolic disturbance in PCOS: clinical and molecular effects on skeletal muscle tissue
WS Dantas, B Gualano, MP Rocha, CR Barcellos, VR Yance, JA Marcondes
The Scientific World JOURNAL 2013
Epidemiology, diagnosis, and management of polycystic ovary syndrome
SM Sirmans, KA Pate
Clinical epidemiology 2013
Effects of insulin-sensitizing agents and insulin resistance in women with polycystic ovary syndrome
KR Hwang, YM Choi, JJ Kim, SJ Chae, KE Park, HW Jeon, SY Ku, SH Kim, JG Kim, SY Moon
Clinical and Experimental Reproductive Medicine 2013
Metabolic syndrome in patients with the polycystic ovary syndrome
D Panidis, K Tziomalos, E Papadakis
Expert Review of Endocrinology & Metabolism 2013
Should all women with PCOS be treated for insulin resistance?
JC Marshall, A Dunaif
Fertility and Sterility 2012
Loss of PKBβ/Akt2 predisposes mice to ovarian cyst formation and increases the severity of polycystic ovary formation in vivo
DF Restuccia, D Hynx, BA Hemmings
Disease models & mechanisms 2012
Cardiometabolic aspects of the polycystic ovary syndrome
HS Randeva, BK Tan, MO Weickert, K Lois, JE Nestler, N Sattar, H Lehnert
Endocrine reviews 2012
Prevalence and Clinical Predictors of Insulin Resistance in Reproductive-Aged Thai Women with Polycystic Ovary Syndrome
T Wongwananuruk, M Rattanachaiyanont, S Indhavivadhana, P Leerasiri, K Techatraisak, P Tanmahasamut, S Angsuwathana, C Dangrat
International Journal of Endocrinology 2012
Disordered follicle development
RJ Chang, H Cook-Andersen
Molecular and Cellular Endocrinology 2012
Insulin Resistance in Pediatric Disease
AA Bremer
Pediatric Annals 2012
A brief history of insulin resistance: from the first insulin radioimmunoassay to selectively targeting protein kinase C pathways
KN Aronis, CS Mantzoros
Metabolism 2012
Insulin-sensitising drugs (metformin, rosiglitazone, pioglitazone, D-chiro-inositol) for women with polycystic ovary syndrome, oligo amenorrhoea and subfertility
T Tang, JM Lord, RJ Norman, E Yasmin, AH Balen, AH Balen
Cochrane Database of Systematic Reviews Reviews 2012
Serum Fetuin-A levels in women with polycystic ovary syndrome
I Gulhan, G Bozkaya, D Oztekin, I Uyar, AG Kebapcilar, B Pamuk
Archives of Gynecology and Obstetrics 2012
Lean mass and insulin resistance in women with polycystic ovary syndrome
KB Comerford, RU Almario, K Kim, SE Karakas
Metabolism 2012
Subclinical inflammation in obese women with polycystic ovary syndrome
DG Elkholi, SF Hammoudah
Middle East Fertility Society Journal 2012
Reproduction and Metabolism: Insights from Polycystic Ovary Syndrome
P Jasti, A Dunaif
Endocrinology and Metabolism 2012
The effect of obesity on polycystic ovary syndrome: a systematic review and meta-analysis: Obesity and central obesity in PCOS
SS Lim, RJ Norman, MJ Davies, LJ Moran
Obesity Reviews 2012
Infertilidad femenina de origen endocrino
G Robin, C Ferte-Delbende, C Proust-Richard, W Karouz, D Dewailly, S Catteau-Jonard
EMC - Ginecología-Obstetricia 2012
Endocrinologie en Gynécologie et Obstétrique
G Robin, S Catteau-Jonard, C Proust-Richard, C Decanter, D Dewailly
Endocrinologie en Gynécologie et Obstétrique 2012
Infertilités féminines d’origine endocrinienne
G Robin, C Ferte-Delbende, C Proust-Richard, W Karouz, D Dewailly, S Catteau-Jonard
EMC - Gynécologie 2012
Early impaired β-cell function in chinese women with polycystic ovary syndrome
T Tao, S Li, A Zhao, X Mao, W Liu
International journal of clinical and experimental pathology 2012
Insulin Resistance and the Polycystic Ovary Syndrome Revisited: An Update on Mechanisms and Implications
E Diamanti-Kandarakis, A Dunaif
Endocrine reviews 2012
Association of acanthosis nigricans and skin tags with insulin resistance
MT Barbato, PR Criado, AK da Silva, E Averbeck, MB Guerine, NB de Sá
Anais Brasileiros de Dermatologia 2012
Metabolic Syndrome
M Wang
Metabolic Syndrome 2011
The Metabolic Syndrome
S Devaraj, D Siegel, I Jialal
The Metabolic Syndrome 2011
Metabolic and endocrine effects of long-chain versus essential omega-3 polyunsaturated fatty acids in polycystic ovary syndrome
ML Vargas, RU Almario, W Buchan, K Kim, SE Karakas
Metabolism 2011
Current perspectives of insulin resistance and polycystic ovary syndrome : Insulin resistance and polycystic ovary syndrome
JM Pauli, N Raja-Khan, X Wu, RS Legro
Diabetic Medicine 2011
Understanding polycystic ovarian syndrome pathogenesis: an updated of its genetic aspects
A E Calogero, V Calabrò, M Catanuso, R A Condorelli, S La Vignera
Journal of Endocrinological Investigation 2011
Insulin resistance is not conserved in myotubes established from women with PCOS
M Eriksen, AD Pørneki, V Skov, JS Burns, H Beck-Nielsen, D Glintborg, M Gaster
PloS one 2010
Insulin Resistance and Metabolic Syndrome in the Pediatric Population
RA M.D., AA Ph.D
Metabolic Syndrome and Related Disorders 2010
Polycystic Ovary Syndrome in the Pediatric Population
AA Bremer
Metabolic Syndrome and Related Disorders 2010
Insulin resistance/hyperinsulinemia and reproductive disorders in infertile women
T Sakumoto, Y Tokunaga, H Tanaka, M Nohara, E Motegi, T Shinkawa, A Nakaza, M Higashi
Reproductive Medicine and Biology 2010
Differential effects of walnuts vs almonds on improving metabolic and endocrine parameters in PCOS
S Kalgaonkar, RU Almario, D Gurusinghe, EM Garamendi, W Buchan, K Kim, SE Karakas
European Journal of Clinical Nutrition 2010
Impact of obesity on gynecology
S Pandey, S Bhattacharya
Women's Health 2010
Determinants of impaired fasting glucose versus glucose intolerance in polycystic ovary syndrome
SE Karakas, K Kim, AJ Duleba
Diabetes care 2010
SNP analysis of follistatin gene associated with polycystic ovarian syndrome
P Panneerselvam, K Sivakumari, P Jayaprakash, R Srikanth
Advances and applications in bioinformatics and chemistry : AABC 2010
Skeletal Muscle Insulin Resistance in Endocrine Disease
M Peppa, C Koliaki, P Nikolopoulos, SA Raptis
Journal of Biomedicine and Biotechnology 2010
The role of chronic inflammation and Leu55Met PON1 polymorphism in the pathogenesis of polycystic ovary syndrome
A Lenarcik, BŻ Bidzińska-Speichert, U Tworowska-Bardzińska
Gynecological Endocrinology 2010
Insulin Resistance Is Not Conserved in Myotubes Established from Women with PCOS
M Eriksen, AD Pørneki, V Skov, JS Burns, H Beck-Nielsen, D Glintborg, M Gaster, K Stadler
PloS one 2010
Pulmonary surfactant: an immunological perspective
ZC Chroneos, Z Sever-Chroneos, VL Shepherd
Cellular physiology and biochemistry : international journal of experimental cellular physiology, biochemistry, and pharmacology 2009
Insulin and hyperandrogenism in women with polycystic ovary syndrome
CG Baptiste, MC Battista, A Trottier, JP Baillargeon
The Journal of Steroid Biochemistry and Molecular Biology 2009
Targeting insulin sensitivity in the treatment of polycystic ovary syndrome
R Pasquali, A Gambineri
Expert Opinion on Therapeutic Targets 2009
Mitochondrial Complex I Impairment in Leukocytes from Polycystic Ovary Syndrome Patients with Insulin Resistance
VM Victor, M Rocha, C Bañuls, M Sanchez-Serrano, E Sola, M Gomez, A Hernandez-Mijares
The Journal of clinical endocrinology and metabolism 2009
Yen & Jaffe's Reproductive Endocrinology
RA Lobo
Yen & Jaffe's Reproductive Endocrinology 2009
111/121 diplotype of Calpain-10 is associated with the risk of polycystic ovary syndrome in Korean women
JY Lee, WJ Lee, SE Hur, CM Lee, YA Sung, HW Chung
Fertility and Sterility 2009
Phosphatidylinositol 3-kinase p85  regulatory subunit gene Met326Ile polymorphism in women with polycystic ovary syndrome
JJ Kim, YM Choi, MA Hong, SS Hwang, SH Yoon, SJ Chae, BC Jee, SY Ku, JG Kim, SY Moon
Human Reproduction 2009
A randomized placebo-controlled study on the effects of pioglitazone on cortisol metabolism in polycystic ovary syndrome
D Glintborg, AP Hermann, C Hagen, LT Jensen, J Frystyk, P Bennett, A Flyvbjerg, M Andersen
Fertility and Sterility 2009
Parametrial Adipose Tissue and Metabolic Dysfunctions Induced by Fructose-rich Diet in Normal and Neonatal-androgenized Adult Female Rats
A Alzamendi, D Castrogiovanni, HH Ortega, RC Gaillard, A Giovambattista, E Spinedi
Obesity 2009
Effect of testosterone on insulin stimulated IRS1 Ser phosphorylation in primary rat myotubes--a potential model for PCOS-related insulin resistance
MC Allemand, BA Irving, YW Asmann, KA Klaus, L Tatpati, CC Coddington, KS Nair
PloS one 2009
Adipose tissue, metabolic syndrome and polycystic ovary syndrome: from pathophysiology to treatment
G Garruti, R Depalo, MG Vita, F Lorusso, F Giampetruzzi, AB Damato, F Giorgino
Reproductive BioMedicine Online 2009
Local recruitment experience in a study comparing the effectiveness of a low glycaemic index diet with a low calorie healthy eating approach at achieving weight loss and reducing the risk of endometrial cancer in women with polycystic ovary syndrome (PCOS)
W Atiomo, A Read, M Golding, P Silcocks, N Razali, S Sarkar, P Hardiman, J Thornton
Contemporary clinical trials 2009
Yen & Jaffe's Reproductive Endocrinology
SF Thung, ER Norwitz
Yen & Jaffe's Reproductive Endocrinology 2009
Genetic variation in exon 17 of INSR is associated with insulin resistance and hyperandrogenemia among lean Indian women with polycystic ovary syndrome
S Mukherjee, N Shaikh, S Khavale, G Shinde, P Meherji, N Shah, A Maitra
European Journal of Endocrinology 2009
Genetic overlap between polycystic ovary syndrome and bipolar disorder: The endophenotype hypothesis
B Jiang, HA Kenna, NL Rasgon
Medical Hypotheses 2009
The role of genes in the polycystic ovary syndrome: Predisposition and mechanisms
E Deligeoroglou, C Kouskouti, P Christopoulos
Gynecological Endocrinology 2009
Effect of Testosterone on Insulin Stimulated IRS1 Ser Phosphorylation in Primary Rat Myotubes—A Potential Model for PCOS-Related Insulin Resistance
MC Allemand, BA Irving, YW Asmann, KA Klaus, L Tatpati, CC Coddington, KS Nair, C Zhang
PloS one 2009
Diagnosis and Management of Polycystic Ovary Syndrome
NR Farid, E Diamanti-Kandarakis
2009
Prevalence of cardiovascular diseases and type 2 diabetes mellitus in perimenopausal women with a history of the polycystic ovary syndrome
P Popova, EV Baranova, EN Grineva
2009
Pathways leading to phosphorylation of p450c17 and to the posttranslational regulation of androgen biosynthesis
MK Tee, Q Dong, WL Miller
Endocrinology 2008
Series in Maternal-Fetal Medicine
BE Metzger
Textbook of Diabetes and Pregnancy 2008
The serine phosphorylation hypothesis of polycystic ovary syndrome: a unifying mechanism for hyperandrogenemia and insulin resistance
AA Bremer, WL Miller
Fertility and Sterility 2008
Proteomics and genomics: A hypothesis-free approach to the study of the role of visceral adiposity in the pathogenesis of the polycystic ovary syndrome
HF Escobar-Morreale, M Insenser, M Cortón, JL san Millán, B Peral
PROTEOMICS – CLINICAL APPLICATIONS 2008
Polymorphism in postinsulin receptor signaling pathway is not associated with polycystic ovary syndrome
MR Jones, SG Wilson, BH Mullin, R Mead, F Dudbridge, GF Watts, BG Stuckey
Fertility and Sterility 2008
Therapeutic response to metformin in an underweight patient with polycystic ovarian syndrome
E Al-Ozairi, R Quinton, A Advani
Fertility and Sterility 2008
Cardiometabolic features of polycystic ovary syndrome
LK Hoffman, DA Ehrmann
Nature Clinical Practice Endocrinology & Metabolism 2008
Basic Infertility Including Polycystic Ovary Syndrome
M Brassard, Y AinMelk, JP Baillargeon
Medical Clinics of North America 2008
Calpain-10 Polymorphism in Korean Women with Polycystic Ovary Syndrome
H Lee, GW Pyun, EK Byun, JY Oh, JY Oh, Y Hong, YA Sung, HW Chung
Journal of Korean Endocrine Society 2008
Polycystic ovarian syndrome: pathophysiology, molecular aspects and clinical implications
E Diamanti-Kandarakis
Expert Reviews in Molecular Medicine 2008
Polycystic Ovary Syndrome in Adolescence
SK Blank, KD Helm, CR McCartney, JC Marshall
Annals of the New York Academy of Sciences 2008
The role of membrane glycoprotein plasma cell antigen 1/ectonucleotide pyrophosphatase phosphodiesterase 1 in the pathogenesis of insulin resistance and related abnormalities
ID Goldfine, BA Maddux, JF Youngren, G Reaven, D Accili, V Trischitta, R Vigneri, L Frittitta
Endocrine reviews 2008
Disorders of Energy Balance
RH Lustig, R Weiss
Pediatric Endocrinology 2008
Defects in insulin signaling pathways in ovarian steroidogenesis and other tissues in polycystic ovary syndrome (PCOS)
E Diamanti-Kandarakis, G Argyrakopoulou, F Economou, E Kandaraki, M Koutsilieris
The Journal of Steroid Biochemistry and Molecular Biology 2008
Impact of metformin and rosiglitazone treatment on glucose transporter 4 mRNA expression in women with polycystic ovary syndrome
M Jensterle, A Janez, B Mlinar, J Marc, J Prezelj, M Pfeifer
European Journal of Endocrinology 2008
Abnormal response of insulin to glucose loading and assessment of insulin resistance in non-obese patients with polycystic ovary syndrome
T Takeuchi, O Tsutsumi, Y Taketani
Gynecological Endocrinology 2008
Myo-inositol administration positively affects hyperinsulinemia and hormonal parameters in overweight patients with polycystic ovary syndrome
AD Genazzani, C Lanzoni, F Ricchieri, VM Jasonni
Gynecological Endocrinology 2008
Impaired Insulin Activation and Dephosphorylation of Glycogen Synthase in Skeletal Muscle of Women with Polycystic Ovary Syndrome Is Reversed by Pioglitazone Treatment
D Glintborg, K Højlund, NR Andersen, BF Hansen, H Beck-Nielsen, JF Wojtaszewski
The Journal of clinical endocrinology and metabolism 2008
Das polyzystische Ovarsyndrom – Metabolische Konsequenzen
S Tan, S Hahn, OE Janssen
Gynäkologisch-geburtshilfliche Rundschau 2008
Genomics in Endocrinology
S Handwerger, B Aronow
2008
Metabolic Profile in Sons of Women with Polycystic Ovary Syndrome
SE Recabarren, R Smith, R Rios, M Maliqueo, B Echiburú, E Codner, F Cassorla, P Rojas, T Sir-Petermann
The Journal of clinical endocrinology and metabolism 2008
Effects of Intrabrachial Metacholine Infusion on Muscle Capillary Recruitment and Forearm Glucose Uptake during Physiological Hyperinsulinemia in Obese, Insulin-Resistant Individuals
G Murdolo, M Sjöstrand, L Strindberg, S Gudbjörnsdóttir, L Lind, P Lönnroth, PA Jansson
The Journal of clinical endocrinology and metabolism 2008
Impaired Insulin-Stimulated Phosphorylation of Akt and AS160 in Skeletal Muscle of Women With Polycystic Ovary Syndrome Is Reversed by Pioglitazone Treatment
K Hojlund, D Glintborg, NR Andersen, JB Birk, JT Treebak, C Frosig, H Beck-Nielsen, JF Wojtaszewski
Diabetes 2007
Polycystic Ovary Syndrome
MA Brown, RJ Chang
Ultrasound Quarterly 2007
The Genetic Basis of the Polycystic Ovary Syndrome: A Literature Review Including Discussion of PPAR-γ
U Unluturk, A Harmanci, C Kocaefe, BO Yildiz
PPAR Research 2007
Total and high molecular weight (HMW) adiponectin levels and measures of glucose and lipid metabolism following pioglitazone treatment in a randomized placebo-controlled study in polycystic ovary syndrome
D Glintborg, J Frystyk, K Højlund, KK Andersen, JE Henriksen, AP Hermann, C Hagen, A Flyvbjerg, M Andersen
Clinical Endocrinology 2007
The adipose cell lineage is not intrinsically insulin resistant in polycystic ovary syndrome
A Corbould, A Dunaif
Metabolism 2007
Investigation of hypothalamo-pituitary-gonadal axis and glucose intolerance among the first-degree female relatives of women with polycystic ovary syndrome
K Ünlühızarcı, M Özocak, F Tanrıverdi, H Atmaca, F Keleştimur
Fertility and Sterility 2007
Peroxisome Proliferator-activated Receptor-γ (PPARγ) Polymorphism in Korean Women with Polycystic Ovary Syndrome
JY Oh, H Lee, YS Hong, YA Sung, HW Chung
The Journal of Korean Diabetes Association 2007
Role of obesity and adiposity in polycystic ovary syndrome
E Diamanti-Kandarakis
International Journal of Obesity 2007
Molecular mechanisms of insulin resistance and associated diseases
B Mlinar, J Marc, A Janež, M Pfeifer
Clinica Chimica Acta 2007
Impairment in insulin sensitivity after early androgenization in the post-pubertal female rat
M Perello, D Castrogiovanni, A Giovambattista, RC Gaillard, E Spinedi
Life Sciences 2007
Syndrome des ovaires polymicrokystiques
G Robin, C Richard-Proust, S Jonard-Catteau, D Dewailly
EMC - Endocrinologie - Nutrition 2007
Effects of ghrelin administration on endocrine and metabolic parameters in obese women with polycystic ovary syndrome
A Fusco, A Bianchi, A Mancini, D Milardi, A Giampietro, V Cimino, T Porcelli, D Romualdi, M Guido, A Lanzone, A Pontecorvi, LD Marinis
Journal of Endocrinological Investigation 2007
Changes in Glucose Tolerance with Metformin Treatment in Polycystic Ovary Syndrome: A Retrospective Analysis
ST Sharma, EP Wickham, JE Nestler
Endocrine Practice 2007
Polycystic ovary syndrome in men: Stein–Leventhal syndrome revisited
R Kurzrock, PR Cohen
Medical Hypotheses 2007
Reduced Expression of Nuclear-Encoded Genes Involved in Mitochondrial Oxidative Metabolism in Skeletal Muscle of Insulin-Resistant Women With Polycystic Ovary Syndrome
V Skov, D Glintborg, S Knudsen, T Jensen, TA Kruse, Q Tan, K Brusgaard, H Beck-Nielsen, K Hojlund
Diabetes 2007
Type 2 Diabetes: Principles and Practice, Second Edition
L Adams
Type 2 Diabetes: Principles and Practice, Second Edition 2007
Amelioration of insulin resistance in women with PCOS via reduced insulin receptor substrate-1 Ser312 phosphorylation following laparoscopic ovarian electrocautery
KM Seow, CC Juan, YP Hsu, JL Hwang, LW Huang, LT Ho
Human Reproduction 2007
Raised Serum, Adipocyte, and Adipose Tissue Retinol-Binding Protein 4 in Overweight Women with Polycystic Ovary Syndrome: Effects of Gonadal and Adrenal Steroids
BK Tan, J Chen, H Lehnert, R Kennedy, HS Randeva
The Journal of clinical endocrinology and metabolism 2007
Androgen Excess Disorders in Women
R Azziz, JE Nestler, D Dewailly
2007
Insulin Resistance and Polycystic Ovarian Syndrome
E Diamanti-Kandarakis, JE Nestler, D Panidis, R Pasquali
2007
Differential Gene Expression Profile in Omental Adipose Tissue in Women with Polycystic Ovary Syndrome
M Cortón, JI Botella-Carretero, A Benguría, G Villuendas, A Zaballos, JL Millán, HF Escobar-Morreale, B Peral
The Journal of clinical endocrinology and metabolism 2007
Enhanced mitogenic signaling in skeletal muscle of women with polycystic ovary syndrome
A Corbould, H Zhao, S Mirzoeva, F Aird, A Dunaif
Diabetes 2006
Selecting controls is not selecting “normals”: Design and analysis issues for studying the etiology of polycystic ovary syndrome
MS Bloom, EF Schisterman, ML Hediger
Fertility and Sterility 2006
Effect of pioglitazone on glucose metabolism and luteinizing hormone secretion in women with polycystic ovary syndrome
D Glintborg, AP Hermann, M Andersen, C Hagen, H Beck-Nielsen, JD Veldhuis, JE Henriksen
Fertility and Sterility 2006
Obesity and insulin resistance but not hyperandrogenism mediates vascular dysfunction in women with polycystic ovary syndrome
A Dokras, DH Jagasia, M Maifeld, CA Sinkey, BJ VanVoorhis, WG Haynes
Fertility and Sterility 2006
Prevention of diabetes and cardiovascular disease in women with PCOS: Treatment with insulin sensitizers
ST Sharma, JE Nestler
Best Practice & Research Clinical Endocrinology & Metabolism 2006
Thiazolidinediones for the Therapeutic Management of Polycystic Ovary Syndrome
KE Elkind-Hirsch
Treatments in Endocrinology 2006
Molecular mechanisms of insulin resistance in polycystic ovary syndrome
E Diamanti-Kandarakis, AG Papavassiliou
Trends in Molecular Medicine 2006
Adiponectin and Ghrelin Polymorphism in Korean Women with Polycystic Ovary Syndrome
H Lee, EK Byun, HR Park, JY Oh, Y Hong, YA Sung, H Chung
Journal of Korean Endocrine Society 2006
Natural Approaches for Treating Polycystic Ovary Syndrome
CD Meletis, N Zabriskie
Alternative and Complementary Therapies 2006
Genomic variants in polycystic ovary syndrome
M Luque-Ramírez, JL san Millán, HF Escobar-Morreale
Clinica Chimica Acta 2006
Genética del síndrome de ovarios poliquísticos
P Amato, JL Simpson
EMC - Ginecología-Obstetricia 2006
Endocrine regulation of HOX genes
GS Daftary, HS Taylor
Endocrine reviews 2006
Génétique du syndrome des ovaires polykystiques
P Amato, JL Simpson
EMC - Gynécologie 2006
Contemporary medical therapy for polycystic ovary syndrome
MS Lanham, DI Lebovic, SE Domino
International Journal of Gynecology & Obstetrics 2006
Third Annual World Congress on the Insulin Resistance Syndrome: Associated conditions
ZT Bloomgarden
Diabetes care 2006
Mutation analysis of the WNT-4 gene in patients with polycystic ovary syndrome
P Canto, D Söderlund, S Carranza-Lira, JP Méndez
Gynecological Endocrinology 2006
Use of Metformin for Ovulation Induction in Women Who Have Polycystic Ovary Syndrome With or Without Evidence of Insulin Resistance
KE Liu, IV Tataryn, M Sagle
Journal of Obstetrics and Gynaecology Canada 2006
Stress in Women: Metabolic Syndrome and Polycystic Ovary Syndrome
E Diamanti-Kandarakis, F Economou
Annals of the New York Academy of Sciences 2006
Insulin Resistance in PCOS
E Diamanti-Kandarakis
Endocrine 2006
The Molecular-Genetic Basis of Functional Hyperandrogenism and the Polycystic Ovary Syndrome
HF Escobar-Morreale, M Luque-Ramírez, JL Millán
Endocrine reviews 2005
Nutrition and Diabetes
R Hoeldtke
Nutrition and Diabetes 2005
Insulin Resistance in Polycystic Ovarian Disease
V Bhatia
Southern Medical Journal 2005
Increased levels of serum advanced glycation end-products in women with polycystic ovary syndrome
E Diamanti-Kandarakis, C Piperi, A Kalofoutis, G Creatsas
Clinical Endocrinology 2005
Metformin alters insulin signaling and viability of human granulosa cells
B Sonntag, M Götte, P Wülfing, AN Schüring, L Kiesel, RR Greb
Fertility and Sterility 2005
Metabolic and cardiovascular risk in the polycystic ovary syndrome
AJ Cussons, BG Stuckey, GF Watts
Practical Diabetes International 2005
High prevalence of metabolic syndrome among young women with premature coronary artery disease
H Turhan, AS Yasar, N Basar, A Bicer, AR Erbay, E Yetkin
Coronary Artery Disease 2005
Pediatric Endocrinology
PS Thornton
Pediatric Endocrinology 2005
Ultra-short metformin pretreatment for clomiphene citrate-resistant polycystic ovary syndrome
YM Hwu, SY Lin, WY Huang, MH Lin, RK Lee
International Journal of Gynecology & Obstetrics 2005
Polycystic ovary syndrome in adolescent girls
SM Pfeifer
Seminars in Pediatric Surgery 2005
Ovaires micropolykystiques et syndrome d’insulinorésistance
Y Lorcy
Annales d'Endocrinologie 2005
Diagnosis and Treatment of Polycystic Ovarian Syndrome and Insulin Resistance
A Fleischman, J Mansfield
Pediatric Annals 2005
Pro12Ala polymorphism of the peroxisome proliferator-activated receptor-γ gene in first-degree relatives of subjects with polycystic ovary syndrome
M Yilmaz, MA Ergün, A Karakoç, E Yurtçu, İ Yetkin, G Ayvaz, N Çakir, M Arslan
Gynecological Endocrinology 2005
Genetics of polycystic ovary syndrome: searching for the way out of the labyrinth
E Diamanti-Kandarakis, C Piperi
Human Reproduction Update 2005
Insulin resistance in the skeletal muscle of women with PCOS involves intrinsic and acquired defects in insulin signaling
A Corbould, YB Kim, JF Youngren, C Pender, BB Kahn, A Lee, A Dunaif
American journal of physiology. Endocrinology and metabolism 2005
Hiperandrogenismo e pele: síndrome do ovário policístico e resistência periférica à insulina
S Yarak, E Bagatin, KM Hassun, MO Parada, ST Filho
Anais Brasileiros de Dermatologia 2005
Combined lifestyle modification and metformin in obese patients with polycystic ovary syndrome. A randomized, placebo-controlled, double-blind multicentre study
T Tang, J Glanville, CJ Hayden, D White, JH Barth, AH Balen
Human Reproduction 2005
Glucose intolerance, insulin resistance and cardiovascular risk factors in first degree relatives of women with polycystic ovary syndrome
M Yılmaz, N Bukan, R Ersoy, A Karakoç, İ Yetkin, G Ayvaz, N Çakır, M Arslan
Human Reproduction 2005
No evidence of mutations in the P450 aromatase gene in patients with polycystic ovary syndrome
D Söderlund, P Canto, S Carranza-Lira, JP Méndez
Human Reproduction 2005
Impaired insulin-dependent glucose metabolism in granulosa-lutein cells from anovulatory women with polycystic ovaries
S Rice, N Christoforidis, C Gadd, D Nikolaou, L Seyani, A Donaldson, R Margara, K Hardy, S Franks
Human Reproduction 2005
Evaluation of glucose metabolism and reproductive hormones in polycystic ovary syndrome on the basis of peroxisome proliferator-activated receptor (PPAR)-γ2 Pro12Ala genotype
EC Tok, A Aktas, D Ertunc, EM Erdal, S Dilek
Human Reproduction 2005
The importance of IRS-1 Gly972Arg polymorphism in evaluating the response to metformin treatment in polycystic ovary syndrome
D Ertunc, EC Tok, A Aktas, EM Erdal, S Dilek
Human Reproduction 2005
Insulin-sensitizing agents: use in pregnancy and as therapy in polycystic ovary syndrome
MA Checa, A Requena, C Salvador, R Tur, J Callejo, JJ Espinós, F Fábregues, J Herrero
Human Reproduction Update 2005
Disorders of Androgen Synthesis – from Cholesterol to Dehydroepiandrosterone
WL Miller
Medical Principles and Practice 2005
Alterations in Mitogen-Activated Protein Kinase Kinase and Extracellular Regulated Kinase Signaling in Theca Cells Contribute to Excessive Androgen Production in Polycystic Ovary Syndrome
VL Nelson-Degrave, JK Wickenheisser, KL Hendricks, T Asano, M Fujishiro, RS Legro, SR Kimball, JF Strauss, JM McAllister
Molecular Endocrinology 2005
The pathophysiology of polycystic ovary syndrome
T Tsilchorozidou, C Overton, GS Conway
Clinical Endocrinology 2004
Prevalence of endocrine diseases and abnormal glucose tolerance tests in 340 caucasian premenopausal women with hirsutism as the referral diagnosis
D Glintborg, JE Henriksen, M Andersen, C Hagen, J Hangaard, PE Rasmussen, K Schousboe, AP Hermann
Fertility and Sterility 2004
The Relationship Between Polycystic Ovary Syndrome and Antiepileptic Drugs
N Rasgon
Journal of Clinical Psychopharmacology 2004
Recent advances in the treatment of polycystic ovary syndrome
BO Yildiz
Expert Opinion on Investigational Drugs 2004
The insulin resistant subphenotype of polycystic ovary syndrome: clinical parameters and pathogenesis
E Mor, A Zograbyan, P Saadat, A Bayrak, DE Tourgeman, C Zhang, FZ Stanczyk, RJ Paulson
American Journal of Obstetrics and Gynecology 2004
Pathogenesis of polycystic ovary syndrome: what is the role of obesity?
M Salehi, R Bravo-Vera, A Sheikh, A Gouller, L Poretsky
Metabolism 2004
Genetic contributions to glucose intolerance in polycystic ovary syndrome
DA Ehrmann
Reproductive BioMedicine Online 2004
The genetics of polycystic ovary syndrome
P Amato, JL Simpson
Best Practice & Research Clinical Obstetrics & Gynaecology 2004
Understanding and managing disturbances in insulin metabolism and body weight in women with polycystic ovary syndrome
L Moran, RJ Norman
Best Practice & Research Clinical Obstetrics & Gynaecology 2004
Insulin resistance and metformin in polycystic ovary syndrome
A Ben-Haroush, Y Yogev, B Fisch
European Journal of Obstetrics & Gynecology and Reproductive Biology 2004
The pathogenesis of infertility and early pregnancy loss in polycystic ovary syndrome
ZM van der Spuy, SJ Dyer
Best Practice & Research Clinical Obstetrics & Gynaecology 2004
Serum leptin elevation in obese women with PCOs: a continuing controversy
HA Saleh, MA El-Nwaem, MM El-Bordiny, HM Maqlad, AA El-Mohandes, EM Eldaqaq
Journal of Assisted Reproduction and Genetics 2004
Metformin versus flutamide in the treatment of metabolic consequences of non-obese young women with polycystic ovary syndrome: a randomized prospective study
I Sahin, R Serter, F Karakurt, B Demirbas, C Culha, C Taskapan, F Kosar, Y Aral
Gynecological Endocrinology 2004
Insulin Augmentation of 17α-Hydroxylase Activity Is Mediated by Phosphatidyl Inositol 3-Kinase But Not Extracellular Signal-Regulated Kinase-1/2 in Human Ovarian Theca Cells
I Munir, HW Yen, DH Geller, D Torbati, RM Bierden, SR Weitsman, SK Agarwal, DA Magoffin
Endocrinology 2004
Regulation of HOXA-10 expression by testosterone in vitro and in the endometrium of patients with polycystic ovary syndrome
D Cermik, B Selam, HS Taylor
The Journal of clinical endocrinology and metabolism 2003
Selective impairment of insulin signalling in the hypothalamus of obese Zucker rats
JB Carvalheira, EB Ribeiro, EP Araújo, RB Guimarães, MM Telles, M Torsoni, JA Gontijo, LA Velloso, MJ Saad
Diabetologia 2003
Genetic and environmental aspect of polycystic ovary syndrome
E Carmina
Journal of Endocrinological Investigation 2003
International Textbook of Diabetes Mellitus
RA DeFronzo, L Mandarino, E Ferrannini
International Textbook of Diabetes Mellitus 2003
Die Insulinresistenz beim polyzystischen Ovar-Syndrom
AK Schröder, S Tauchert, O Ortmann, K Diedrich, JM Weiss
Wiener klinische Wochenschrift 2003
Insulin Resistant States and Insulin Signaling
P Vollenweider
Clinical Chemistry and Laboratory Medicine 2003
Relationship between insulin resistance and gonadotropin dissociation in obese and nonobese women with polycystic ovary syndrome
C Moran, E Garcia-Hernandez, E Barahona, S Gonzalez, JA Bermudez
Fertility and Sterility 2003
Androgen excess is the key element in polycystic ovary syndrome
R Azziz
Fertility and Sterility 2003
The polycystic ovary syndrome: what does insulin resistance have to do with it?
I Ben-Shlomo
Reproductive BioMedicine Online 2003
Treatment of the adolescent patient with polycystic ovary syndrome
SM Pfeifer, M Dayal
Obstetrics and Gynecology Clinics of North America 2003
The Ovary
BC Vanderhyden, TJ Shaw, K Garson, AM Tonary
The Ovary 2003
Efecto del clorhidrato de metformina sobre el metabolismo en mujeres con síndrome de ovarios poliquísticos
F González-González, O Nicolau, J Essien, J Bardales
Clínica e Investigación en Ginecología y Obstetricia 2003
Insulin-Lowering Agents in the Management of Polycystic Ovary Syndrome
VD Leo, A la Marca, F Petraglia
Endocrine reviews 2003
Exon 6 and 2 Peroxisome Proliferator-Activated Receptor-γ Polymorphisms in Polycystic Ovary Syndrome
F Orio, G Matarese, SD Biase, S Palomba, D Labella, V Sanna, S Savastano, F Zullo, A Colao, G Lombardi
The Journal of clinical endocrinology and metabolism 2003
Metabolic and molecular basis of insulin resistance
M Bajaj
Journal of Nuclear Cardiology 2003
Insulin resistance and polycystic ovary syndrome
DA Ehrmann
Current Diabetes Reports 2002
Strategies for the use of insulin-sensitizing drugs to treat infertility in women with polycystic ovary syndrome
JE Nestler, D Stovall, N Akhter, MJ Iuorno, DJ Jakubowicz
Fertility and Sterility 2002
Molecular progress in infertility: polycystic ovary syndrome
RS Legro, JF Strauss
Fertility and Sterility 2002
Comparison of metformin and thiazolidinediones in the management of polycystic ovary syndrome
JP Baillargeon, MJ Iuorno, JE Nestler
Current Opinion in Endocrinology & Diabetes 2002
Genetic analysis of candidate genes for the polycystic ovary syndrome
M Urbanek, RS Spielman
Current Opinion in Endocrinology & Diabetes 2002
Insulin resistance: what is its role in the polycystic ovary syndrome?
P Moghetti
Current Opinion in Endocrinology & Diabetes 2002
New Approach to Polycystic Ovary Syndrome and Other Forms of Anovulatory Infertility
JS Laven, B Imani, MJ Eijkemans, BC Fauser
Obstetrical & Gynecological Survey 2002
Androgen biosynthesis from cholesterol to DHEA
WL Miller
Molecular and Cellular Endocrinology 2002
Androgen and lipid profiles in adolescents with polycystic ovary syndrome who were treated with two forms of combined oral contraceptives
G Mastorakos, C Koliopoulos, G Creatsas
Fertility and Sterility 2002
Insulin Resistance and Insulin Resistance Syndrome: An Allosteric Point of View
J Larner
Insulin Resistance and Insulin Resistance Syndrome 2002
Medical Management of Diabetes and Heart Disease
M LeWinter
Medical Management of Diabetes and Heart Disease 2002
EFFECTS OF D-CHIRO-INOSITOL IN LEAN WOMEN WITH THE POLYCYSTIC OVARY SYNDROME
MJ MD, DJ MD, JP MD, PD BS, RD MS, GA PhD, JE MD
Endocrine Practice 2002
Insulin Resistance in the Sisters of Women with Polycystic Ovary Syndrome: Association with Hyperandrogenemia Rather Than Menstrual Irregularity
RS Legro, R Bentley-Lewis, D Driscoll, SC Wang, A Dunaif
The Journal of clinical endocrinology and metabolism 2002
Metformin and Polycystic Ovary Syndrome: A Literature Review
KA Awartani, AP Cheung
Journal of Obstetrics and Gynaecology Canada 2002
Insulin: does it induce follicular arrest in the rat ovary?
NK Kuşcu, F Koyuncu, K Özbilgin, S İnan, I Tuğlu, Ö Karaer
Gynecological Endocrinology 2002
CURRENTCONCEPTS IN THEPOLYCYSTICOVARYSYNDROME
A Dunaif, A Thomas
Annual Review of Medicine 2001
Why can’t a man be more like a mouse?: Reply of the authors
C Moran, R Azziz
Fertility and Sterility 2001
Altered autophosphorylation of the insulin receptor in the ovary of a woman with polycystic ovary syndrome
C Moran, R Huerta, BA Conway-Myers, GA Hines, R Azziz
Fertility and Sterility 2001
Metformin directly inhibits androgen production in human thecal cells
GR Attia, WE Rainey, BR Carr
Fertility and Sterility 2001
The influence of obesity on hyperandrogenism and infertility in the female
E Diamanti-Kandarakis, A Bergiele
Obesity Reviews 2001
Polycystic Ovarian Syndrome in Women with Epilepsy: A Review
S Duncan
Epilepsia 2001
Polycystic Ovary Syndrome Hyperandrogenism, and Insulin Resistance
HA Zacur
Obstetrics and Gynecology Clinics of North America 2001
The Role Of The Adrenal Cortex In Polycystic Ovary Syndrome
C Moran, R Azziz
Obstetrics and Gynecology Clinics of North America 2001
Improved responsiveness of PCOS patients to clomiphene after CYP17a inhibitor
HA Hassan, D El-Gezeiry, TM Nafaa, I Baghdady
Journal of Assisted Reproduction and Genetics 2001
Polycystic Ovary Syndrome and lnsulin Resistance: New Approaches to Management, including Exercise
S Laredo, ME Hannah, R Casper, D Feig, L Leiter, CD Rodgers
Journal SOGC 2001
Defects in insulin receptor signaling in vivo in the polycystic ovary syndrome (PCOS)
A Dunaif, X Wu, A Lee, E Diamanti-Kandarakis
American journal of physiology. Endocrinology and metabolism 2001
Clinical, endocrine and metabolic effects of acarbose, an α-glucosidase inhibitor, in PCOS patients with increased insulin response and normal glucose tolerance
L Ciotta, AE Calogero, M Farina, VD Leo, AL Marca, A Cianci
Human Reproduction 2001
Genetics of Diabetes Mellitus
WL Lowe
2001
Insulin resistance differentially affects the PI 3-kinase– and MAP kinase–mediated signaling in human muscle
K Cusi, K Maezono, A Osman, M Pendergrass, ME Patti, T Pratipanawatr, RA DeFronzo, CR Kahn, LJ Mandarino
Journal of Clinical Investigation 2000
The long term health consequences of polycystic ovary syndrome
CJ Kelly, JM Connell, IT Cameron, GW Gould, H Lyall
BJOG: An International Journal of Obstetrics and Gynaecology 2000
Expression of insulin-receptor substrate-1 and -2 in ovaries from women with insulin resistance and from controls
XK Wu, K Sallinen, L Anttila, M Mäkinen, C Luo, P Pöllänen, R Erkkola
Fertility and Sterility 2000
Insulin resistance and the polycystic ovary syndrome: recent advances
JE Nestler
Current Opinion in Endocrinology & Diabetes 2000
Handbook of the Assisted Reproduction Laboratory
B Lessey, L Lovely
Handbook of the Assisted Reproduction Laboratory 2000
Hyperinsulinaemia and polycystic ovary syndrome
GS Conway
Human Fertility 2000
Impaired insulin action on granulosa-lutein cells in women with polycystic ovary syndrome and insulin resistance
P Fedorcsák, R Storeng, PO Dale, T Tanbo, T Åbyholm
Gynecological Endocrinology 2000
Protein kinase C modulates insulin action in human skeletal muscle
RN Cortright, JL Azevedo, Q Zhou, M Sinha, WJ Pories, SI Itani, GL Dohm
American journal of physiology. Endocrinology and metabolism 2000
Insulin sensitivity, insulin secretion, and metabolic and hormonal parameters in healthy women and women with polycystic ovarian syndrome
LC Morin-Papunen, I Vauhkonen, RM Koivunen, A Ruokonen, JS Tapanainen
Human Reproduction 2000
The Importance of Diagnosing the Polycystic Ovary Syndrome
RA Lobo, E Carmina
Annals of internal medicine 2000
Premature Adrenarche—Normal Variant or Forerunner of Adult Disease?*
L Ibáñez, J DiMartino-Nardi, N Potau, P Saenger
Endocrine reviews 2000
The molecular basis of premature adrenarche: an hypothesis
WL Miller
Acta Paediatrica 1999
Role of PC-1 in The Etiology of Insulin Resistance
ID Goldfine, BA Maddux, JF Youngren, V Trischitta, L Frittitta
Annals of the New York Academy of Sciences 1999
INSULIN ACTION IN THE POLYCYSTIC OVARY SYNDROME
A Dunaif
Endocrinology & Metabolism Clinics of North America 1999
INSULIN-LOWERING THERAPEUTIC MODALITIES FOR POLYCYSTIC OVARY SYNDROME
DA Ehrmann
Endocrinology & Metabolism Clinics of North America 1999
Serum leptin as an additional possible pathogenic factor in polycystic ovary syndrome
HE Orabi, AA Ghalia, A Khalifa, H Mahfouz, AE Shalkani, N Shoieb
Clinical Biochemistry 1999
Thirty-seven candidate genes for polycystic ovary syndrome: strongest evidence for linkage is with follistatin
M Urbanek, RS Legro, DA Driscoll, R Azziz, DA Ehrmann, RJ Norman, JF 3rd, RS Spielman, A Dunaif
Proceedings of the National Academy of Sciences 1999
POLYCYSTIC OVARY SYNDROME
RS Legro
Endocrinology & Metabolism Clinics of North America 1999
Thirty-seven candidate genes for polycystic ovary syndrome: Strongest evidence for linkage is with follistatin
M Urbanek, RS Legro, DA Driscoll, R Azziz, DA Ehrmann, RJ Norman, JF Strauss, RS Spielman, A Dunaif
Proceedings of the National Academy of Sciences 1999
MENSTRUAL DISORDERS IN ADOLESCENTS
CM Gordon
Pediatric Clinics of North America 1999
Unraveling the riddle of insulin resistance
ID Goldfine
Journal of Laboratory and Clinical Medicine 1999
Endocrine and metabolic effects of octreotide, a somatostatin analogue, in lean PCOS patients with either hyperinsulinaemia or lean normoinsulinaemia
L Ciotta, VD Leo, F Galvani, AL Marca, A Cianci
Human Reproduction 1999
Molecular Mysteries of Polycystic Ovary Syndrome
JF Strauss, A Dunaif
Molecular Endocrinology 1999
Adrenal Hyperandrogenism in Children
L Ghizzoni, G Mastorakos, A Vottero
The Journal of clinical endocrinology and metabolism 1999
The Insulin-Related Ovarian Regulatory System in Health and Disease
L Poretsky, NA Cataldo, Z Rosenwaks, LC Giudice
Endocrine reviews 1999
Dephosphorylation increases insulin-stimulated receptor kinase activity in skeletal muscle of obese Zucker rats
Q Zhou, P L Dolan, G L Dohm
Molecular and Cellular Biochemistry 1999
Insulin Resistance, Polycystic Ovary Syndrome and Metformin:
M Pugeat, PH Ducluzeau
Drugs 1999
Understanding the underlying metabolic abnormalities of polycystic ovary syndrome and their implications
AE Taylor
American Journal of Obstetrics and Gynecology 1998
Insulin action and insulin resistance: diseases involving defects in insulin receptors, signal transduction, and the glucose transport effector system
S Hunter
The American Journal of Medicine 1998
New approaches to insulin resistance in polycystic ovarian syndrome
RM Davison
Current Opinion in Obstetrics and Gynaecology 1998
Genetics of polycystic ovary syndrome
S Franks, N Gharani, D Waterworth, S Batty, D White, R Williamson, M McCarthy
Molecular and Cellular Endocrinology 1998
Leptin: physiology and pathophysiology
G Frühbeck, SA Jebb, AM Prentice
Clinical Physiology 1998
Current Developments in the Molecular Genetics of the Polycystic Ovary Syndrome
S Franks, N Gharani, D Waterworth, S Batty, D White, R Williamson, M McCarthy
Trends in Endocrinology & Metabolism 1998
The Development of the Polycystic Ovary Syndrome: Family History as a Risk Factor
M Kahsar-Miller, R Azziz
Trends in Endocrinology & Metabolism 1998
The Regulation of Human P450c17 Activity: Relationship to Premature Adrenarche, Insulin Resistance and the Polycystic Ovary Syndrome
RJ Auchus, DH Geller, TC Lee, WL Miller
Trends in Endocrinology & Metabolism 1998
Insights into the Development of Polycystic Ovary Syndrome (PCOS) from Studies of Prenatally Androgenized Female Rhesus Monkeys
DH Abbott, DA Dumesic, JR Eisner, RJ Colman, JW Kemnitz
Trends in Endocrinology & Metabolism 1998
Human Chorionic Gonadotropin Stimulation to Assess for Ovarian Hyperandrogenism
SF Witchel, PA Lee
Journal of Pediatric and Adolescent Gynecology 1998
17α-Hydroxylase/17,20-Lyase Dysregulation Is Not Caused by Mutations in the Coding Regions of CYP17
SF Witchel, PA Lee, M Suda-Hartman, R Smith, EP Hoffman
Journal of Pediatric and Adolescent Gynecology 1998
The insulin receptor--a critical link in glucose homeostasis and insulin action
ME Patti, CR Kahn
Journal of Basic and Clinical Physiology and Pharmacology 1998
Polycystic ovary syndrome and insulin resistance: Thrifty genes struggling with over-feeding and sedentary life style?
J Holte
Journal of Endocrinological Investigation 1998
Role of GnRH drive in the pathophysiology of polycystic ovary syndrome
MP Leondires, SL Berga
Journal of Endocrinological Investigation 1998
The pathogenesis of polycystic ovary syndrome: Lessons from ovarian stimulation studies
RB Barnes
Journal of Endocrinological Investigation 1998
Lack of insulin resistance in fibroblasts from subjects with polycystic ovary syndrome
TP Ciaraldi, AJ Morales, MG Hickman, R Odom-Ford, SS Yen, JM Olefsky
Metabolism 1998
Early steps in androgen biosynthesis: From cholesterol to DHEA
WL Miller
Baillière's Clinical Endocrinology and Metabolism 1998
Insulin and polycystic ovary syndrome: A new look at an old subject
M Ciampelli, A Lanzone
Gynecological Endocrinology 1998
Involvement of growth factors in the pathophysiology of polycystic ovary syndrome
R Homburg
Gynecological Endocrinology 1998
Insulin Action
AK Srivastava, BI Posner
1998
Syndromes of Severe Insulin Resistance
NA Tritos, CS Mantzoros
The Journal of clinical endocrinology and metabolism 1998
Membrane glycoprotein PC-1 and insulin resistance
I D Goldfine, B A Maddux, J F Youngren, L Frittitta, V Trischitta, G L Dohm
Molecular and Cellular Biochemistry 1998
The Polycystic Ovary Syndrome Pathogenesis, Metabolic Implications, and Therapeutic Approach
E Diamanti-Kandarakis
Annals of the New York Academy of Sciences 1997
PATHOPHYSIOLOGY, GENETICS, AND TREATMENT OF HYPERANDROGENISM
WL Miller
Pediatric Clinics of North America 1997
Decreased muscle insulin receptor kinase correlates with insulin resistance in normoglycemic Pima Indians
JF Youngren, ID Goldfine, RE Pratley
American journal of physiology. Endocrinology and metabolism 1997
Clinical Research in Diabetes and Obesity
B Draznin, R Rizza
1997
Insulin Resistance and the Polycystic Ovary Syndrome: Mechanism and Implications for Pathogenesis*
A Dunaif
Endocrine reviews 1997
Alterations in the Insulin Signaling Pathway Induced by Immortalization and H-ras Transformation of Brown Adipocytes*
AM Valverde, M Lorenzo, T Teruel, M Benito
Endocrinology 1997
Leptin Concentrations in the Polycystic Ovary Syndrome1
CS Mantzoros, A Dunaif, JS Flier
The Journal of clinical endocrinology and metabolism 1997
New perspectives in polycystic ovary syndrome
E Diamanti-Kandarakis, A Dunaif
Trends in Endocrinology & Metabolism 1996
Decreases in Ovarian Cytochrome P450c17α Activity and Serum Free Testosterone after Reduction of Insulin Secretion in Polycystic Ovary Syndrome
JE Nestler, DJ Jakubowicz
New England Journal of Medicine 1996
World Literature
SF Witchel
Journal of Pediatric and Adolescent Gynecology 1996
Disturbances in insulin secretion and sensitivity in women with the polycystic ovary syndrome
J Holte
Baillière's Clinical Endocrinology and Metabolism 1996
Polycystic ovary syndrome: the present position
HS Jacobs
Gynecological Endocrinology 1996
Hyperinsulinemia is common in family members of women with polycystic ovary syndrome**Supported by the National Health and Medical Research Council, Canberra, Australian Capital Territory, Australia
RJ Norman, S Masters, W Hague
Fertility and Sterility 1996
Obesity and Diabetes
M Smith, R Levine
Medical Clinics of North America 1964
Insulin Resistance
A Voll, J Kloster
Acta Medica Scandinavica 1957

← Previous 1 2 3 … 14 15 Next →

Advertisement

Copyright © 2025 American Society for Clinical Investigation
ISSN: 0021-9738 (print), 1558-8238 (online)

Sign up for email alerts

Posted by 1 X users
Referenced in 1 patents
Referenced in 1 clinical guideline sources
265 readers on Mendeley
See more details